Industries > Food and Drink > Animal Antibiotics & Antimicrobial Market Report to 2031
Animal Antibiotics & Antimicrobial Market Report to 2031
Forecasts by Product Type (Penicillins, Tetracyclines, Macrolides, Aminoglycosides, Sulfanomides, Fluroquinolones, Lincosamides, Cephalosporins, Others), By Mode of Administration (Premixes, Oral Powders, Oral Solutions, Injections, Others), By Animal Class (Bovine, Swine, Poultry, Ovies Aries, Equine, Canine, Feline, Others) PLUS Profiles of Leading Almond Protein Manufacturing Companies and Regional and Leading National Market Analysis, PLUS COVID-19 Recovery Scenarios
Animal Antibiotics and Antimicrobial Market– our new study reveals trends, R&D progress, and predicted revenues
Where is the Animal Antibiotics and Antimicrobial Market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 377 page report provides 407 tables and 409 charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Animal Antibiotics and Antimicrobial Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Animal Antibiotics and Antimicrobial Market: by Product Type
• Penicillins
• Tetracyclines
• Macrolides
• Aminoglycosides
• Sulfonamides
• Fluroquinolones
• Lincosamides
• Cephalosporins
• Others
Animal Antibiotics and Antimicrobial Market: by Mode of Administration
• Premixes
• Oral Powders
• Oral Solutions
• Injections
• Others
Animal Antibiotics and Antimicrobial Market: by Animal Class
• Bovine
• Swine
• Poultry
• Ovies Aries
• Equine
• Canine
• Feline
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 22 leading national markets:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Netherlands
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o Australia
o South Korea
o Southeast Asia
o Rest of Asia Pacific
• South America
o Brazil
o Colombia
o Argentina
o Mexico
o Rest of Latin America
• Middle East & Africa
o Turkey
o Saudi Arabia
o South Africa
o UAE
o Egypt
o Rest of Middle East and Africa
The report also includes profiles and for some of the leading companies in the Animal Antibiotics and Antimicrobial Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Animal Antibiotics and Antimicrobial Market will surpass $ xx million in 2021, our work calculates. We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Animal Antibiotics and Antimicrobial Market report helps you
In summary, our 350+ page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Animal Antibiotics and Antimicrobial Market, with forecasts for Product Type, Mode of Administration, and Animal Class, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2030 for 5 regional and 22 key national markets– See forecasts for the Animal Antibiotics and Antimicrobial Market in North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. Also forecasted is the market in the US, Canada, Argentina, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Animal Antibiotics and Antimicrobial Market. Some of the company’s profiled in this report include Zoetis Inc, Boehringer Ingelheim GmbH, Eli Lilly & Company, Merck Group, and Bayer AG among others.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Animal Antibiotics & Antimicrobial Market Report to 2031: Forecasts by Product Type (Penicillins, Tetracyclines, Macrolides, Aminoglycosides, Sulfanomides, Fluroquinolones, Lincosamides, Cephalosporins, Others), By Mode of Administration (Premixes, Oral Powders, Oral Solutions, Injections, Others), By Animal Class (Bovine, Swine, Poultry, Ovies Aries, Equine, Canine, Feline, Others) PLUS Profiles of Leading Almond Protein Manufacturing Companies and Regional and Leading National Market Analysis, PLUS COVID-19 Recovery Scenarios . Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Animal Antibiotics and Antimicrobial Market
2.1. Animal Antibiotics and Antimicrobial Market Definition
2.2. Product Type Submarkets Definitions
2.3. Mode of Administration Submarkets Definitions
2.4. Animal Class Submarkets Definitions
3. Animal Antibiotics and Antimicrobial Market Overview
3.1. Global Animal Antibiotics and Antimicrobial Market Size and Forecast by Region
3.2. Global Animal Antibiotics and Antimicrobial Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Growing Meat Consumption
3.3.1.2. Rising Prevalence of Animal borne Diseases
3.3.1.3. Growing Pet Adoption
3.3.2. Market Restraints/Challenges
3.3.2.1. Rising Vegan Population Base
3.3.2.2. Lack of Product Developments in the Antibiotics Space
3.3.3. Opportunities
3.3.3.1. Penetration of IoT in Supply Chain Leading to Transparency
3.3.4. Global Animal Antibiotics and Antimicrobial Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Animal Antibiotics and Antimicrobial Market Analysis and Forecast 2021-2031, by Product Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Penicillins
4.1.1.1. Growing Antimicrobial Resistance Among Microbes Hampering Market Growth
4.1.2. Tetracyclines
4.1.2.1. Persistent Demand for Tetracycline Among Animal Patients
4.1.3. Macrolides
4.1.3.1. Prevalence of Infectious Diseases among Animals
4.1.4. Aminoglycosides
4.1.4.1. Growing Prevalence of Telemedicine Driving Market Growth
4.1.5. Sulfonamides
4.1.5.1. Growing Prevalence of Zoonotic Diseases Driving Market Growth
4.1.6. Fluroquinolones
4.1.6.1. High Toxicity of Fluroquinolones Restraining Market Growth
4.1.7. Lincosamides
4.1.7.1. Growing Demand for Meat Consumption
4.1.8. Cephalosporins
4.1.8.1. Growing Investments in the Field of Animal Antibiotics
4.1.9. Others
4.1.9.1. Growing Investments in the Field of Animal Antibiotics
5. Global Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 by Mode of Administration (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Premixes
5.1.1.1. Growth in Feed Production
5.1.2. Oral Powders
5.1.2.1. Growing Demand for Animal Health
5.1.3. Oral Solutions
5.1.3.1. Growing Demand for Pet Insurance in Emerging Nations
5.1.4. Injections
5.1.4.1. Growing Prevalence of Zoonotic Diseases
5.1.5. Others
6. Global Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 by Animal Class (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Bovine
6.1.1.1. High Beef Consumption in Developed Nations
6.1.2. Swine
6.1.2.1. Growing Pork Consumption in Developing Nations such as India
6.1.3. Poultry
6.1.3.1. High Demand for Poultry in India
6.1.4. Ovies Aries
6.1.4.1. High Demand for Lamb and Mutton in Asian Countries
6.1.5. Equine
6.1.5.1. Growing Prevalence of Infectious Diseases in Animals
6.1.6. Canine
6.1.6.1. High Adoption of Dogs Across the Globe
6.1.7. Feline
6.1.7.1. Steady Growth in Cat Adoption
6.1.8. Others
7. North America Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Animal Antibiotics and Antimicrobial Market Size and Forecast by Product Type
7.2.1. Penicillins Submarket Expected to Grow at Fastest Rate
7.3. North America Animal Antibiotics and Antimicrobial Market Size and Forecast by Mode of Administration
7.3.1. Injection Submarket to Grow at Fastest Rate
7.4. North America Animal Antibiotics and Antimicrobial Market Size and Forecast by Animal Class
7.4.1. Bovine Submarket to Grow at Fastest Rate
7.5. U.S. Animal Antibiotics and Antimicrobial Market
7.6. Canada Animal Antibiotics and Antimicrobial Market
8. Europe Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Animal Antibiotics and Antimicrobial Market Size and Forecast by Product Type
8.2.1. Tetracyclines Submarket Expected to Grow at Fastest Rate
8.3. Europe Animal Antibiotics and Antimicrobial Market Size and Forecast by Mode of Administration
8.3.1. Oral Powder Submarket to Grow at Fastest Rate
8.4. Europe Animal Antibiotics and Antimicrobial Market Size and Forecast by Animal Class
8.4.1. Swine Submarket to Grow at Fastest Rate
8.5. UK Animal Antibiotics and Antimicrobial Market
8.6. Germany Animal Antibiotics and Antimicrobial Market
8.7. France Animal Antibiotics and Antimicrobial Market
8.8. Italy Animal Antibiotics and Antimicrobial Market
8.9. Spain Animal Antibiotics and Antimicrobial Market
8.10. Russia Animal Antibiotics and Antimicrobial Market
8.11. Netherlands Animal Antibiotics and Antimicrobial Market
8.12. Rest of Europe Animal Antibiotics and Antimicrobial Market
9. Asia Pacific Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Animal Antibiotics and Antimicrobial Market Size and Forecast by Product Type
9.2.1. Macrolides Submarket Expected to Grow at Fastest Rate
9.3. Asia Pacific Animal Antibiotics and Antimicrobial Market Size and Forecast by Mode of Administration
9.3.1. Oral Solutions Submarket to Grow at Fastest Rate
9.4. Asia Pacific Animal Antibiotics and Antimicrobial Market Size and Forecast by Animal Class
9.4.1. Poultry Submarket to Grow at Fastest Rate
9.5. China Animal Antibiotics and Antimicrobial Market
9.6. India Animal Antibiotics and Antimicrobial Market
9.7. Japan Animal Antibiotics and Antimicrobial Market
9.8. Australia Animal Antibiotics and Antimicrobial Market
9.9. South Korea Animal Antibiotics and Antimicrobial Market
9.10. Southeast Asia Animal Antibiotics and Antimicrobial Market
9.11. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market
10. Latin America Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Animal Antibiotics and Antimicrobial Market Size and Forecast by Product Type
10.2.1. Sulfanomides Submarket Expected to Grow at Fastest Rate
10.3. Latin America Animal Antibiotics and Antimicrobial Market Size and Forecast by Mode of Administration
10.3.1. Injection Submarket to Grow at Fastest Rate
10.4. Latin America Animal Antibiotics and Antimicrobial Market Size and Forecast by Animal Class
10.4.1. Bovine Submarket to Grow at Fastest Rate
10.5. Brazil Animal Antibiotics and Antimicrobial Market
10.6. Colombia Animal Antibiotics and Antimicrobial Market
10.7. Argentina Animal Antibiotics and Antimicrobial Market
10.8. Mexico Animal Antibiotics and Antimicrobial Market
10.9. Rest of Latin America Animal Antibiotics and Antimicrobial Market
11. Middle East & Africa Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Middle East & Africa Animal Antibiotics and Antimicrobial Market Size and Forecast by Product Type
11.2.1. Macrolides Submarket Expected to Grow at Fastest Rate
11.3. Middle East & Africa Animal Antibiotics and Antimicrobial Market Size and Forecast by Mode of Administration
11.3.1. Premixes Submarket to Grow at Fastest Rate
11.4. Middle East & Africa Animal Antibiotics and Antimicrobial Market Size and Forecast by Animal Class
11.4.1. Swine Submarket to Grow at Fastest Rate
11.4.2. Turkey Animal Antibiotics and Antimicrobial Market
11.4.3. Saudi Arabia Animal Antibiotics and Antimicrobial Market
11.4.4. South Africa Animal Antibiotics and Antimicrobial Market
11.4.5. UAE Animal Antibiotics and Antimicrobial Market
11.4.6. Egypt Animal Antibiotics and Antimicrobial Market
11.4.7. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market
12. Companies in the Animal Antibiotics and Antimicrobial Market
12.1. Zoetis Inc.
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2019)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2019
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2018-2020)
12.2. Boehringer Ingelheim GmbH
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2019)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2019
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2018-2020)
12.3. Eli Lilly & Company
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2019)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2019
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2018-2020)
12.4. Merck Group
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2019)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2019
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2018-2020)
12.5. Bayer AG
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2019)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2019
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2018-2020)
12.6. Sanofi SA
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2019)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2019
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2018-2020)
12.7. Virbac
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2019)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2019
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2018-2020)
12.8. Ceva Sante
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2019)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2019
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2018-2020)
12.9. Vetoquinol SA
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2019)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2019
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2018-2020)
12.10. Dechra Pharmaceuticals
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2019)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2019
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2018-2020)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Animal Antibiotics and Antimicrobial Market Drivers & Restraints 2021
Table 7. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 58. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 123. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 128. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 133. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 228. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 233. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 234. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 235. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 236. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 237. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 238. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 239. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 240. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 241. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 242. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 243. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 244. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 245. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 246. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 247. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 248. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 249. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 250. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 251. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 252. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 253. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 254. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 255. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 256. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 257. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 258. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 259. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 260. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 261. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 262. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 263. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 264. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 265. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 266. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 267. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 268. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 269. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 270. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 271. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 272. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 273. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 274. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 275. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 276. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 277. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 278. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 279. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 280. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 281. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 282. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 283. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 284. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 285. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 286. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 287. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 288. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 289. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 290. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 291. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 292. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 293. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 294. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 295. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 296. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 297. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 298. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 299. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 300. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 301. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 302. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 303. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 304. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 305. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 306. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 307. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 308. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 309. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 310. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 311. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 312. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 313. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 314. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 315. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 316. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 317. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 318. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 319. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 320. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 321. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 322. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 323. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 324. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 325. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 326. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 327. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 328. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 329. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 330. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 331. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 332. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 333. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 334. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 335. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 336. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 337. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 338. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 339. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 340. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 341. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 342. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 343. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 344. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 345. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 346. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 347. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 348. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 349. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 350. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 351. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 352. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 353. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 354. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 355. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 356. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 357. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 358. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 359. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 360. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 361. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 362. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 363. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 364. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 365. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 366. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 367. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 368. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 369. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 370. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 371. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 372. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 373. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 374. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 375. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 376. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 377. Leading 10 Animal Antibiotics and Antimicrobial Companies (Ranking, Company, Latest Total Company Sales US$M, HQ)
Table 378. Zoetis Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 379. Zoetis Inc. Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 380. Zoetis Inc. Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 381. Boehringer Ingelheim GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 382. Boehringer Ingelheim GmbH Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 383. Boehringer Ingelheim GmbH Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 384. Eli Lilly & Company Profile 2019 (CEO, HQ, Founded, Website)
Table 385. Eli Lilly & Company Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 386. Eli Lilly & Company Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 387. Merck Group Profile 2019 (CEO, HQ, Founded, Website)
Table 388. Merck Group Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 389. Merck Group Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 390. Bayer AG Profile 2019 (CEO, HQ, Founded, Website)
Table 391. Bayer AG Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 392. Bayer AG Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 393. Sanofi SA Profile 2019 (CEO, HQ, Founded, Website)
Table 394. Sanofi SA Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 395. Sanofi SA Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 396. Virbac Profile 2019 (CEO, HQ, Founded, Website)
Table 397. Virbac Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 398. Virbac Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 399. Ceva Sante Profile 2019 (CEO, HQ, Founded, Website)
Table 400. Ceva Sante Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 401. Ceva Sante Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 402. Vetoquinol S.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 403. Vetoquinol S.A. Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 404. Vetoquinol S.A. Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 405. Dechra Pharmaceuticals Profile 2019 (CEO, HQ, Founded, Website)
Table 406. Dechra Pharmaceuticals Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 407. Dechra Pharmaceuticals Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
LIST OF FIGURES
Figure 1. Animal Antibiotics and Antimicrobial Market Product Type Overview
Figure 2. Animal Antibiotics and Antimicrobial Market Mode of Administration Overview
Figure 3. Animal Antibiotics and Antimicrobial Market Animal Class Overview
Figure 4. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 5. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 6. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 7. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 8. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 9. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 10. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 11. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 12. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 13. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 14. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 15. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 16. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 17. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 18. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 19. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 20. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 35. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 36. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 37. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 38. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 39. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 40. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 41. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 42. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 43. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 44. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 45. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 46. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 47. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 48. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 49. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 50. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 51. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 52. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 53. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 54. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 55. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 56. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 57. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 58. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 59. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 60. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 61. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 62. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 63. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 64. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 65. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 66. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 67. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 68. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 69. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 70. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 71. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 72. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 73. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 74. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 75. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 76. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 77. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 78. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 79. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 80. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 81. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 82. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 83. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 84. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 85. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 86. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 87. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 88. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 89. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 90. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 91. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 92. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 93. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 94. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 95. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 96. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 97. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 98. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 99. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 100. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 101. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 102. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 103. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 104. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 105. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 106. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 107. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 108. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 109. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 110. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 111. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 112. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 113. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 114. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 115. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 116. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 117. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 118. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 119. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 120. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 121. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 122. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 123. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 124. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 125. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 126. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 127. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 128. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 129. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 130. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 131. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 132. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 133. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 134. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 135. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 136. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 137. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 138. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 139. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 140. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 141. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 142. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 143. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 144. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 145. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 146. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 147. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 148. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 149. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 150. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 151. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 152. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 153. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 154. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 155. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 156. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 157. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 158. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 159. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 160. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 161. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 162. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 163. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 164. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 165. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 166. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 167. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 168. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 169. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 170. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 171. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 172. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 173. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 174. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 175. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 176. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 177. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 178. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 179. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 180. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 181. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 182. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 183. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 184. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 185. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 186. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 187. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 188. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 189. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 190. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 191. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 192. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 193. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 194. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 195. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 196. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 197. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 198. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 199. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 200. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 201. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 202. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 203. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 204. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 205. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 206. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 207. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 208. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 209. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 210. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 211. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 212. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 213. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 214. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 215. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 216. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 217. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 218. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 219. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 220. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 221. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 222. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 223. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 224. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 225. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 226. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 227. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 228. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 229. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 230. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 231. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 232. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 233. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 234. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 235. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 236. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 237. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 238. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 239. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 240. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 241. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 242. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 243. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 244. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 245. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 246. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 247. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 248. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 249. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 250. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 251. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 252. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 253. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 254. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 255. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 256. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 257. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 258. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 259. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 260. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 261. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 262. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 263. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 264. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 265. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 266. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 267. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 268. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 269. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 270. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 271. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 272. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 273. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 274. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 275. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 276. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 277. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 278. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 279. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 280. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 281. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 282. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 283. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 284. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 285. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 286. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 287. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 288. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 289. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 290. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 291. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 292. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 293. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 294. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 295. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 296. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 297. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 298. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 299. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 300. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 301. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 302. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 303. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 304. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 305. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 306. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 307. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 308. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 309. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 310. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 311. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 312. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 313. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 314. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 315. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 316. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 317. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 318. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 319. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 320. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 321. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 322. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 323. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 324. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 325. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 326. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 327. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 328. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 329. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 330. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 331. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 332. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 333. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 334. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 335. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 336. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 337. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 338. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 339. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 340. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 341. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 342. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 343. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 344. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 345. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 346. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 347. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 348. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 349. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 350. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 351. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 352. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 353. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 354. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 355. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 356. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 357. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 358. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 359. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 360. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 361. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 362. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 363. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 364. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 365. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 366. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 367. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 368. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 369. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 370. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 371. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 372. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 373. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 374. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 375. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 376. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 377. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 378. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 379. Porter’s Five Force Analysis
Figure 380. Zoetis Inc. Total Company Sales 2015-2019 (US$m, AGR %)
Figure 381. Zoetis Inc. Sales by Segment of Business 2019 (US$m)
Figure 382. Zoetis Inc. Sales by Regional Segment of Business 2019 (US$m)
Figure 383. Boehringer Ingelheim GmbH Total Company Sales 2015-2019 (US$m, AGR %)
Figure 384. Boehringer Ingelheim GmbH Sales by Segment of Business 2019 (US$m)
Figure 385. Boehringer Ingelheim GmbH Sales by Regional Segment of Business 2019 (US$m)
Figure 386. Eli Lilly & Company Total Company Sales 2015-2019 (US$m, AGR %)
Figure 387. Eli Lilly & Company Sales by Segment of Business 2019 (US$m)
Figure 388. Eli Lilly & Company Sales by Regional Segment of Business 2019 (US$m)
Figure 389. Merck Group Total Company Sales 2015-2019 (US$m, AGR %)
Figure 390. Merck Group Sales by Segment of Business 2019 (US$m)
Figure 391. Merck Group Sales by Regional Segment of Business 2019 (US$m)
Figure 392. Bayer AG Total Company Sales 2015-2019 (US$m, AGR %)
Figure 393. Bayer AG Sales by Segment of Business 2019 (US$m)
Figure 394. Bayer AG Sales by Regional Segment of Business 2019 (US$m)
Figure 395. Sanofi SA Total Company Sales 2015-2019 (US$m, AGR %)
Figure 396. Sanofi SA Sales by Segment of Business 2019 (US$m)
Figure 397. Sanofi SA Sales by Regional Segment of Business 2019 (US$m)
Figure 398. Virbac Total Company Sales 2015-2019 (US$m, AGR %)
Figure 399. Virbac Sales by Segment of Business 2019 (US$m)
Figure 400. Virbac Sales by Regional Segment of Business 2019 (US$m)
Figure 401. Ceva Sante Total Company Sales 2015-2019 (US$m, AGR %)
Figure 402. Ceva Sante Sales by Segment of Business 2019 (US$m)
Figure 403. Ceva Sante Sales by Regional Segment of Business 2019 (US$m)
Figure 404. Vetoquinol S.A. Total Company Sales 2015-2019 (US$m, AGR %)
Figure 405. Vetoquinol S.A. Sales by Segment of Business 2019 (US$m)
Figure 406. Vetoquinol S.A. Sales by Regional Segment of Business 2019 (US$m)
Figure 407. Dechra Pharmaceuticals Total Company Sales 2015-2019 (US$m, AGR %)
Figure 408. Dechra Pharmaceuticals Sales by Segment of Business 2019 (US$m)
Figure 409. Dechra Pharmaceuticals Sales by Regional Segment of Business 2019 (US$m)
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Introduction to the Animal Antibiotics and Antimicrobial Market
2.1. Animal Antibiotics and Antimicrobial Market Definition
2.2. Product Type Submarkets Definitions
2.3. Mode of Administration Submarkets Definitions
2.4. Animal Class Submarkets Definitions
3. Animal Antibiotics and Antimicrobial Market Overview
3.1. Global Animal Antibiotics and Antimicrobial Market Size and Forecast by Region
3.2. Global Animal Antibiotics and Antimicrobial Market Share by Region
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Growing Meat Consumption
3.3.1.2. Rising Prevalence of Animal borne Diseases
3.3.1.3. Growing Pet Adoption
3.3.2. Market Restraints/Challenges
3.3.2.1. Rising Vegan Population Base
3.3.2.2. Lack of Product Developments in the Antibiotics Space
3.3.3. Opportunities
3.3.3.1. Penetration of IoT in Supply Chain Leading to Transparency
3.3.4. Global Animal Antibiotics and Antimicrobial Market: Trends
3.3.5. SWOT Analysis
3.3.5.1. Strengths
3.3.5.2. Weaknesses
3.3.5.3. Opportunities
3.3.5.4. Threats
3.3.6. Porter’s Five Forces Analysis
3.3.6.1. Competitive Rivalry
3.3.6.2. Supplier Power
3.3.6.3. Buyer Power
3.3.6.4. Threat of Substitution
3.3.6.5. Threat of New Entry
4. Global Animal Antibiotics and Antimicrobial Market Analysis and Forecast 2021-2031, by Product Type (Pre COVID and V, U, W and L COVID Recovery Scenarios)
4.1. Market Overview
4.1.1. Penicillins
4.1.1.1. Growing Antimicrobial Resistance Among Microbes Hampering Market Growth
4.1.2. Tetracyclines
4.1.2.1. Persistent Demand for Tetracycline Among Animal Patients
4.1.3. Macrolides
4.1.3.1. Prevalence of Infectious Diseases among Animals
4.1.4. Aminoglycosides
4.1.4.1. Growing Prevalence of Telemedicine Driving Market Growth
4.1.5. Sulfonamides
4.1.5.1. Growing Prevalence of Zoonotic Diseases Driving Market Growth
4.1.6. Fluroquinolones
4.1.6.1. High Toxicity of Fluroquinolones Restraining Market Growth
4.1.7. Lincosamides
4.1.7.1. Growing Demand for Meat Consumption
4.1.8. Cephalosporins
4.1.8.1. Growing Investments in the Field of Animal Antibiotics
4.1.9. Others
4.1.9.1. Growing Investments in the Field of Animal Antibiotics
5. Global Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 by Mode of Administration (Pre COVID and V, U, W and L COVID Recovery Scenarios)
5.1. Market Overview
5.1.1. Premixes
5.1.1.1. Growth in Feed Production
5.1.2. Oral Powders
5.1.2.1. Growing Demand for Animal Health
5.1.3. Oral Solutions
5.1.3.1. Growing Demand for Pet Insurance in Emerging Nations
5.1.4. Injections
5.1.4.1. Growing Prevalence of Zoonotic Diseases
5.1.5. Others
6. Global Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 by Animal Class (Pre COVID and V, U, W and L COVID Recovery Scenarios)
6.1. Market Overview
6.1.1. Bovine
6.1.1.1. High Beef Consumption in Developed Nations
6.1.2. Swine
6.1.2.1. Growing Pork Consumption in Developing Nations such as India
6.1.3. Poultry
6.1.3.1. High Demand for Poultry in India
6.1.4. Ovies Aries
6.1.4.1. High Demand for Lamb and Mutton in Asian Countries
6.1.5. Equine
6.1.5.1. Growing Prevalence of Infectious Diseases in Animals
6.1.6. Canine
6.1.6.1. High Adoption of Dogs Across the Globe
6.1.7. Feline
6.1.7.1. Steady Growth in Cat Adoption
6.1.8. Others
7. North America Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 Pre COVID and V, U, W and L COVID Recovery Scenarios)
7.1. Market Overview
7.2. North America Animal Antibiotics and Antimicrobial Market Size and Forecast by Product Type
7.2.1. Penicillins Submarket Expected to Grow at Fastest Rate
7.3. North America Animal Antibiotics and Antimicrobial Market Size and Forecast by Mode of Administration
7.3.1. Injection Submarket to Grow at Fastest Rate
7.4. North America Animal Antibiotics and Antimicrobial Market Size and Forecast by Animal Class
7.4.1. Bovine Submarket to Grow at Fastest Rate
7.5. U.S. Animal Antibiotics and Antimicrobial Market
7.6. Canada Animal Antibiotics and Antimicrobial Market
8. Europe Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
8.1. Market Overview
8.2. Europe Animal Antibiotics and Antimicrobial Market Size and Forecast by Product Type
8.2.1. Tetracyclines Submarket Expected to Grow at Fastest Rate
8.3. Europe Animal Antibiotics and Antimicrobial Market Size and Forecast by Mode of Administration
8.3.1. Oral Powder Submarket to Grow at Fastest Rate
8.4. Europe Animal Antibiotics and Antimicrobial Market Size and Forecast by Animal Class
8.4.1. Swine Submarket to Grow at Fastest Rate
8.5. UK Animal Antibiotics and Antimicrobial Market
8.6. Germany Animal Antibiotics and Antimicrobial Market
8.7. France Animal Antibiotics and Antimicrobial Market
8.8. Italy Animal Antibiotics and Antimicrobial Market
8.9. Spain Animal Antibiotics and Antimicrobial Market
8.10. Russia Animal Antibiotics and Antimicrobial Market
8.11. Netherlands Animal Antibiotics and Antimicrobial Market
8.12. Rest of Europe Animal Antibiotics and Antimicrobial Market
9. Asia Pacific Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
9.1. Market Overview
9.2. Asia Pacific Animal Antibiotics and Antimicrobial Market Size and Forecast by Product Type
9.2.1. Macrolides Submarket Expected to Grow at Fastest Rate
9.3. Asia Pacific Animal Antibiotics and Antimicrobial Market Size and Forecast by Mode of Administration
9.3.1. Oral Solutions Submarket to Grow at Fastest Rate
9.4. Asia Pacific Animal Antibiotics and Antimicrobial Market Size and Forecast by Animal Class
9.4.1. Poultry Submarket to Grow at Fastest Rate
9.5. China Animal Antibiotics and Antimicrobial Market
9.6. India Animal Antibiotics and Antimicrobial Market
9.7. Japan Animal Antibiotics and Antimicrobial Market
9.8. Australia Animal Antibiotics and Antimicrobial Market
9.9. South Korea Animal Antibiotics and Antimicrobial Market
9.10. Southeast Asia Animal Antibiotics and Antimicrobial Market
9.11. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market
10. Latin America Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
10.1. Market Overview
10.2. Latin America Animal Antibiotics and Antimicrobial Market Size and Forecast by Product Type
10.2.1. Sulfanomides Submarket Expected to Grow at Fastest Rate
10.3. Latin America Animal Antibiotics and Antimicrobial Market Size and Forecast by Mode of Administration
10.3.1. Injection Submarket to Grow at Fastest Rate
10.4. Latin America Animal Antibiotics and Antimicrobial Market Size and Forecast by Animal Class
10.4.1. Bovine Submarket to Grow at Fastest Rate
10.5. Brazil Animal Antibiotics and Antimicrobial Market
10.6. Colombia Animal Antibiotics and Antimicrobial Market
10.7. Argentina Animal Antibiotics and Antimicrobial Market
10.8. Mexico Animal Antibiotics and Antimicrobial Market
10.9. Rest of Latin America Animal Antibiotics and Antimicrobial Market
11. Middle East & Africa Animal Antibiotics and Antimicrobial Market Analysis and Forecast, 2021-2031 (Pre COVID and V, U, W and L COVID Recovery Scenarios)
11.1. Market Overview
11.2. Middle East & Africa Animal Antibiotics and Antimicrobial Market Size and Forecast by Product Type
11.2.1. Macrolides Submarket Expected to Grow at Fastest Rate
11.3. Middle East & Africa Animal Antibiotics and Antimicrobial Market Size and Forecast by Mode of Administration
11.3.1. Premixes Submarket to Grow at Fastest Rate
11.4. Middle East & Africa Animal Antibiotics and Antimicrobial Market Size and Forecast by Animal Class
11.4.1. Swine Submarket to Grow at Fastest Rate
11.4.2. Turkey Animal Antibiotics and Antimicrobial Market
11.4.3. Saudi Arabia Animal Antibiotics and Antimicrobial Market
11.4.4. South Africa Animal Antibiotics and Antimicrobial Market
11.4.5. UAE Animal Antibiotics and Antimicrobial Market
11.4.6. Egypt Animal Antibiotics and Antimicrobial Market
11.4.7. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market
12. Companies in the Animal Antibiotics and Antimicrobial Market
12.1. Zoetis Inc.
12.1.1. Company Snapshot
12.1.2. Company Overview
12.1.3. Financial Performance (2015-2019)
12.1.3.1. Net Revenue
12.1.3.2. Gross Profit
12.1.3.3. Geographical Revenue, 2019
12.1.4. Product Offerings
12.1.5. Recent Initiatives (2018-2020)
12.2. Boehringer Ingelheim GmbH
12.2.1. Company Snapshot
12.2.2. Company Overview
12.2.3. Financial Performance (2015-2019)
12.2.3.1. Net Revenue
12.2.3.2. Gross Profit
12.2.3.3. Geographical Revenue, 2019
12.2.4. Product Offerings
12.2.5. Recent Initiatives (2018-2020)
12.3. Eli Lilly & Company
12.3.1. Company Snapshot
12.3.2. Company Overview
12.3.3. Financial Performance (2015-2019)
12.3.3.1. Net Revenue
12.3.3.2. Gross Profit
12.3.3.3. Geographical Revenue, 2019
12.3.4. Product Offerings
12.3.5. Recent Initiatives (2018-2020)
12.4. Merck Group
12.4.1. Company Snapshot
12.4.2. Company Overview
12.4.3. Financial Performance (2015-2019)
12.4.3.1. Net Revenue
12.4.3.2. Gross Profit
12.4.3.3. Geographical Revenue, 2019
12.4.4. Product Offerings
12.4.5. Recent Initiatives (2018-2020)
12.5. Bayer AG
12.5.1. Company Snapshot
12.5.2. Company Overview
12.5.3. Financial Performance (2015-2019)
12.5.3.1. Net Revenue
12.5.3.2. Gross Profit
12.5.3.3. Geographical Revenue, 2019
12.5.4. Product Offerings
12.5.5. Recent Initiatives (2018-2020)
12.6. Sanofi SA
12.6.1. Company Snapshot
12.6.2. Company Overview
12.6.3. Financial Performance (2015-2019)
12.6.3.1. Net Revenue
12.6.3.2. Gross Profit
12.6.3.3. Geographical Revenue, 2019
12.6.4. Product Offerings
12.6.5. Recent Initiatives (2018-2020)
12.7. Virbac
12.7.1. Company Snapshot
12.7.2. Company Overview
12.7.3. Financial Performance (2015-2019)
12.7.3.1. Net Revenue
12.7.3.2. Gross Profit
12.7.3.3. Geographical Revenue, 2019
12.7.4. Product Offerings
12.7.5. Recent Initiatives (2018-2020)
12.8. Ceva Sante
12.8.1. Company Snapshot
12.8.2. Company Overview
12.8.3. Financial Performance (2015-2019)
12.8.3.1. Net Revenue
12.8.3.2. Gross Profit
12.8.3.3. Geographical Revenue, 2019
12.8.4. Product Offerings
12.8.5. Recent Initiatives (2018-2020)
12.9. Vetoquinol SA
12.9.1. Company Snapshot
12.9.2. Company Overview
12.9.3. Financial Performance (2015-2019)
12.9.3.1. Net Revenue
12.9.3.2. Gross Profit
12.9.3.3. Geographical Revenue, 2019
12.9.4. Product Offerings
12.9.5. Recent Initiatives (2018-2020)
12.10. Dechra Pharmaceuticals
12.10.1. Company Snapshot
12.10.2. Company Overview
12.10.3. Financial Performance (2015-2019)
12.10.3.1. Net Revenue
12.10.3.2. Gross Profit
12.10.3.3. Geographical Revenue, 2019
12.10.4. Product Offerings
12.10.5. Recent Initiatives (2018-2020)
12.11. Other Notable Players
13. Conclusion
14. Glossary
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A
About Visiongain
Appendix B
Visiongain report evaluation form
LIST OF TABLES
Table 1. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 2. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 3. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 4. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 5. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 6. Animal Antibiotics and Antimicrobial Market Drivers & Restraints 2021
Table 7. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 8. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 9. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 10. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 11. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 12. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 13. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 14. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 15. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 16. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 17. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 18. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 19. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 20. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 21. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 22. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 23. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 24. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 25. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 26. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 27. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 28. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 29. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 30. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 31. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 32. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 33. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 34. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 35. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 36. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 37. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 38. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 39. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 40. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 41. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 42. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 43. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 44. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 45. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 46. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 47. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 48. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 49. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 50. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 51. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 52. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 53. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 54. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 55. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 56. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 57. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 58. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 59. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 60. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 61. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 62. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 63. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 64. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 65. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 66. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 67. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 68. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 69. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 70. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 71. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 72. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 73. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 74. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 75. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 76. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 77. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 78. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 79. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 80. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 81. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 82. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 83. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 84. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 85. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 86. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 87. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 88. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 89. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 90. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 91. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 92. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 93. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 94. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 95. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 96. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 97. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 98. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 99. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 100. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 101. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 102. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 103. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 104. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 105. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 106. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 107. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 108. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 109. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 110. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 111. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 112. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 113. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 114. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 115. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 116. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 117. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 118. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 119. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 120. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 121. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 122. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 123. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 124. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 125. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 126. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 127. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 128. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 129. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Table 130. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Table 131. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Table 132. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Table 133. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Table 134. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 135. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 136. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 137. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 138. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 139. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 140. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 141. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 142. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 143. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 144. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 145. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 146. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 147. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 148. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 149. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 150. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 151. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 152. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 153. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 154. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 155. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 156. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 157. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 158. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 159. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 160. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 161. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 162. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 163. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 164. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 165. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 166. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 167. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 168. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 169. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 170. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 171. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 172. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 173. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 174. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 175. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 176. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 177. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 178. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 179. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 180. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 181. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 182. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 183. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 184. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 185. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 186. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 187. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 188. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 189. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 190. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 191. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 192. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 193. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 194. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 195. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 196. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 197. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 198. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 199. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 200. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 201. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 202. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 203. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 204. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 205. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 206. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 207. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 208. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 209. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 210. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 211. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 212. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 213. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 214. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 215. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 216. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 217. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 218. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 219. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 220. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 221. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 222. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 223. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 224. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 225. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 226. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 227. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 228. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 229. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 230. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 231. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 232. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 233. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 234. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 235. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 236. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 237. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 238. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 239. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 240. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 241. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 242. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 243. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 244. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 245. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 246. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 247. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 248. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 249. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 250. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 251. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 252. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 253. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 254. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 255. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 256. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 257. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 258. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 259. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 260. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 261. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 262. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 263. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 264. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 265. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 266. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 267. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 268. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 269. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 270. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 271. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 272. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 273. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 274. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 275. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 276. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 277. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 278. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 279. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 280. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 281. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 282. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 283. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 284. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 285. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 286. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 287. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 288. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 289. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 290. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 291. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 292. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 293. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 294. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 295. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 296. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 297. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 298. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 299. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 300. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 301. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 302. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 303. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 304. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 305. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 306. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 307. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 308. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 309. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 310. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 311. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 312. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 313. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 314. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 315. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 316. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 317. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 318. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 319. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 320. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 321. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 322. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 323. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 324. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 325. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 326. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 327. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 328. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 329. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 330. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 331. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 332. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 333. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 334. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 335. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 336. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 337. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 338. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 339. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 340. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 341. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 342. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 343. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 344. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 345. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 346. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 347. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 348. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 349. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 350. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 351. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 352. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 353. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 354. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 355. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 356. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 357. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 358. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 359. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 360. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 361. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 362. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 363. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 364. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 365. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 366. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 367. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 368. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 369. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 370. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 371. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 372. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Table 373. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Table 374. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Table 375. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Table 376. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Table 377. Leading 10 Animal Antibiotics and Antimicrobial Companies (Ranking, Company, Latest Total Company Sales US$M, HQ)
Table 378. Zoetis Inc. Profile 2019 (CEO, HQ, Founded, Website)
Table 379. Zoetis Inc. Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 380. Zoetis Inc. Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 381. Boehringer Ingelheim GmbH Profile 2019 (CEO, HQ, Founded, Website)
Table 382. Boehringer Ingelheim GmbH Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 383. Boehringer Ingelheim GmbH Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 384. Eli Lilly & Company Profile 2019 (CEO, HQ, Founded, Website)
Table 385. Eli Lilly & Company Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 386. Eli Lilly & Company Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 387. Merck Group Profile 2019 (CEO, HQ, Founded, Website)
Table 388. Merck Group Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 389. Merck Group Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 390. Bayer AG Profile 2019 (CEO, HQ, Founded, Website)
Table 391. Bayer AG Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 392. Bayer AG Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 393. Sanofi SA Profile 2019 (CEO, HQ, Founded, Website)
Table 394. Sanofi SA Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 395. Sanofi SA Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 396. Virbac Profile 2019 (CEO, HQ, Founded, Website)
Table 397. Virbac Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 398. Virbac Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 399. Ceva Sante Profile 2019 (CEO, HQ, Founded, Website)
Table 400. Ceva Sante Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 401. Ceva Sante Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 402. Vetoquinol S.A. Profile 2019 (CEO, HQ, Founded, Website)
Table 403. Vetoquinol S.A. Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 404. Vetoquinol S.A. Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
Table 405. Dechra Pharmaceuticals Profile 2019 (CEO, HQ, Founded, Website)
Table 406. Dechra Pharmaceuticals Animal Antibiotics and Antimicrobial Selected Recent Contracts 2019 (Date, Programme Type, Details)
Table 407. Dechra Pharmaceuticals Animal Antibiotics and Antimicrobial Product Offering (Segment, Product Offerings)
LIST OF FIGURES
Figure 1. Animal Antibiotics and Antimicrobial Market Product Type Overview
Figure 2. Animal Antibiotics and Antimicrobial Market Mode of Administration Overview
Figure 3. Animal Antibiotics and Antimicrobial Market Animal Class Overview
Figure 4. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %) (Before COVID)
Figure 5. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario V)
Figure 6. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario U)
Figure 7. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario W)
Figure 8. Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %) (COVID - Scenario L)
Figure 9. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 10. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 11. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 12. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 13. Animal Antibiotics and Antimicrobial Submarket Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 14. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 15. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 16. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 17. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 18. Penicillins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 19. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 20. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 21. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 22. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 23. Tetracyclines Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 24. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 25. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 26. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 27. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 28. Macrolides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 29. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 30. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 31. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 32. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 33. Aminoglycosides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 34. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 35. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 36. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 37. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 38. Sulfonamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 39. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 40. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 41. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 42. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 43. Fluroquinolones Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 44. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 45. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 46. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 47. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 48. Lincosamides Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 49. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 50. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 51. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 52. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 53. Cephalosporins Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 54. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 55. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 56. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 57. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 58. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 59. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 60. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 61. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 62. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 63. Animal Antibiotics and Antimicrobial Submarket Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 64. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 65. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 66. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 67. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 68. Premixes Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 69. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 70. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 71. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 72. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 73. Oral Powders Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 74. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 75. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 76. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 77. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 78. Oral Solutions Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 79. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 80. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 81. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 82. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 83. Injections Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 84. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 85. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 86. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 87. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 88. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 89. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 90. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 91. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 92. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 93. Animal Antibiotics and Antimicrobial Submarket Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 94. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 95. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 96. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 97. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 98. Bovine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 99. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 100. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 101. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 102. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 103. Swine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 104. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 105. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 106. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 107. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 108. Poultry Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 109. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 110. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 111. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 112. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 113. Ovies Aries Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 114. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 115. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 116. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 117. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 118. Equine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 119. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 120. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 121. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 122. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 123. Canine Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 124. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 125. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 126. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 127. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 128. Feline Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 129. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 130. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 131. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario U)
Figure 132. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario W)
Figure 133. Others Submarket Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario L)
Figure 134. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (Before COVID)
Figure 135. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$Mn, AGR %, CAGR %) (COVID - Scenario V)
Figure 136. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 137. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 138. Regional Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 139. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 140. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 141. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 142. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 143. North America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 144. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 145. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 146. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 147. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 148. North America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 149. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 150. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 151. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 152. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 153. North America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 154. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 155. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 156. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 157. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 158. North America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 159. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 160. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 161. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 162. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 163. US Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 164. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 165. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 166. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 167. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 168. Canada Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 169. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 170. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 171. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 172. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 173. Europe Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 174. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 175. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 176. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 177. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 178. Europe Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 179. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 180. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 181. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 182. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 183. Europe Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 184. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 185. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 186. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 187. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 188. Europe Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 189. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 190. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 191. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 192. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 193. Germany Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 194. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 195. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 196. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 197. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 198. UK Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 199. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 200. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 201. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 202. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 203. France Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 204. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 205. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 206. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 207. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 208. Spain Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 209. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 210. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 211. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 212. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 213. Italy Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 214. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 215. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 216. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 217. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 218. Netherlands Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 219. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 220. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 221. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 222. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 223. Russia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 224. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 225. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 226. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 227. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 228. Rest of Europe Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 229. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 230. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 231. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 232. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 233. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 234. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 235. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 236. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 237. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 238. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 239. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 240. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 241. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 242. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 243. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 244. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 245. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 246. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 247. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 248. Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 249. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 250. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 251. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 252. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 253. China Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 254. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 255. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 256. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 257. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 258. India Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 259. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 260. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 261. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 262. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 263. Japan Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 264. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 265. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 266. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 267. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 268. Australia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 269. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 270. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 271. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 272. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 273. South Korea Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 274. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 275. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 276. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 277. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 278. South East Asia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 279. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 280. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 281. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 282. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 283. Rest of Asia Pacific Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 284. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 285. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 286. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 287. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 288. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 289. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 290. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 291. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 292. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 293. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 294. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 295. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 296. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 297. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 298. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 299. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 300. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 301. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 302. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 303. Latin America Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 304. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 305. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 306. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 307. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 308. Brazil Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 309. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 310. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 311. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 312. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 313. Mexico Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 314. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 315. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 316. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 317. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 318. Argentina Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 319. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 320. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 321. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 322. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 323. Colombia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 324. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 325. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 326. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 327. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 328. Rest of Latin America Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 329. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 330. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 331. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 332. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 333. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Product Type 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 334. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 335. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 336. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 337. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 338. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Mode of Administration 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 339. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 340. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 341. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 342. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 343. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Animal Class 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 344. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 345. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 346. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 347. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 348. Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast by Country 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 349. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 350. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 351. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 352. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 353. Turkey Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 354. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 355. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 356. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 357. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 358. Saudi Arabia Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 359. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 360. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 361. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 362. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 363. South Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 364. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 365. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 366. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 367. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 368. UAE Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 369. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 370. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 371. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 372. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 373. Egypt Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 374. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (Before COVID)
Figure 375. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario V)
Figure 376. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario U)
Figure 377. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario W)
Figure 378. Rest of Middle East & Africa Animal Antibiotics and Antimicrobial Market Forecast 2021-2031 (US$M, AGR %, CAGR %) (COVID - Scenario L)
Figure 379. Porter’s Five Force Analysis
Figure 380. Zoetis Inc. Total Company Sales 2015-2019 (US$m, AGR %)
Figure 381. Zoetis Inc. Sales by Segment of Business 2019 (US$m)
Figure 382. Zoetis Inc. Sales by Regional Segment of Business 2019 (US$m)
Figure 383. Boehringer Ingelheim GmbH Total Company Sales 2015-2019 (US$m, AGR %)
Figure 384. Boehringer Ingelheim GmbH Sales by Segment of Business 2019 (US$m)
Figure 385. Boehringer Ingelheim GmbH Sales by Regional Segment of Business 2019 (US$m)
Figure 386. Eli Lilly & Company Total Company Sales 2015-2019 (US$m, AGR %)
Figure 387. Eli Lilly & Company Sales by Segment of Business 2019 (US$m)
Figure 388. Eli Lilly & Company Sales by Regional Segment of Business 2019 (US$m)
Figure 389. Merck Group Total Company Sales 2015-2019 (US$m, AGR %)
Figure 390. Merck Group Sales by Segment of Business 2019 (US$m)
Figure 391. Merck Group Sales by Regional Segment of Business 2019 (US$m)
Figure 392. Bayer AG Total Company Sales 2015-2019 (US$m, AGR %)
Figure 393. Bayer AG Sales by Segment of Business 2019 (US$m)
Figure 394. Bayer AG Sales by Regional Segment of Business 2019 (US$m)
Figure 395. Sanofi SA Total Company Sales 2015-2019 (US$m, AGR %)
Figure 396. Sanofi SA Sales by Segment of Business 2019 (US$m)
Figure 397. Sanofi SA Sales by Regional Segment of Business 2019 (US$m)
Figure 398. Virbac Total Company Sales 2015-2019 (US$m, AGR %)
Figure 399. Virbac Sales by Segment of Business 2019 (US$m)
Figure 400. Virbac Sales by Regional Segment of Business 2019 (US$m)
Figure 401. Ceva Sante Total Company Sales 2015-2019 (US$m, AGR %)
Figure 402. Ceva Sante Sales by Segment of Business 2019 (US$m)
Figure 403. Ceva Sante Sales by Regional Segment of Business 2019 (US$m)
Figure 404. Vetoquinol S.A. Total Company Sales 2015-2019 (US$m, AGR %)
Figure 405. Vetoquinol S.A. Sales by Segment of Business 2019 (US$m)
Figure 406. Vetoquinol S.A. Sales by Regional Segment of Business 2019 (US$m)
Figure 407. Dechra Pharmaceuticals Total Company Sales 2015-2019 (US$m, AGR %)
Figure 408. Dechra Pharmaceuticals Sales by Segment of Business 2019 (US$m)
Figure 409. Dechra Pharmaceuticals Sales by Regional Segment of Business 2019 (US$m)
Companies Profiled in the Report
1. Zoetis Inc.
2. Boehringer Ingrelheim GmbH
3. Eil Lilly & Company
4. Merck Group
5. Bayer AG
6. Sanofi SA
7. Virbac
8. Ceva Sante
9. Vetoquinol SA
10. Dechra Pharmaceuticals
Companies Mentioned in the Report
1. Pfizer
2. Elanco Animal
3. Novartis AG
4. Sanofi SA
5. Bioniche Animal Health
6. Fort Dodge Animal Health
7. Merial
8. Covetrus Inc.
9. IDEXX Laboratories Inc.
10. Neogen
11. Bimeda
12. AnimalCare
13. Bioveta
14. Indian Immunologicals
15. Cadila Healthcare
16. Guangdong Haid Group
1. Zoetis Inc.
2. Boehringer Ingrelheim GmbH
3. Eil Lilly & Company
4. Merck Group
5. Bayer AG
6. Sanofi SA
7. Virbac
8. Ceva Sante
9. Vetoquinol SA
10. Dechra Pharmaceuticals
Companies Mentioned in the Report
1. Pfizer
2. Elanco Animal
3. Novartis AG
4. Sanofi SA
5. Bioniche Animal Health
6. Fort Dodge Animal Health
7. Merial
8. Covetrus Inc.
9. IDEXX Laboratories Inc.
10. Neogen
11. Bimeda
12. AnimalCare
13. Bioveta
14. Indian Immunologicals
15. Cadila Healthcare
16. Guangdong Haid Group
Download sample pages
Complete the form below to download your free sample pages for Animal Antibiotics & Antimicrobial Market Report to 2031Download sample pages
Complete the form below to download your free sample pages for Animal Antibiotics & Antimicrobial Market Report to 2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice? If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain food & drink reports are compiled using a broad and rich mixture of both primary and secondary information to produce an overall industry outlook. In order to provide our clients with the best product possible product, we do not rely on any one single source of information. Visiongain analysts reach out to market-leading vendors, carriers, service providers and industry experts but also review a wealth of financial data and product information from a vast range of sources. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Would you like to get the latest Visiongain food & drink reports catalogue? What are the dynamic growth sectors? where are the regional business opportunities? Which technologies will prevail and who are the leading companies succeeding in these sectors and why? If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports. If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987
Assured Food Standards
Europatat
Federation of Oils, Seeds and Fats Associations
Food and Drink Federation
Food & Drink Federation
Grain and Feed Trade Association
Freshfel Europe
International Dairy-Deli-Bakery Association
Meat Industry Association of New Zealand
National Frozen & Refrigerated Foods Association
Produce Marketing Association
TURYID
U.S. Poultry & Egg Association
Visiongain Food & Drink
Visiongain Food & Drink
Visiongain Food & DrinkLatest Food and Drink news
Visiongain Publishes Vertical Farming Market Report 2023-2033
The global Vertical Farming market was valued at US$5.4 billion in 2022 and is projected to grow at a CAGR of 22% during the forecast period 2023-2033.
31 July 2023
Visiongain Publishes Industrial Enzymes Market Report 2023-2033
The global industrial enzymes market was valued at US$6.42 billion in 2022 and is projected to grow at a CAGR of 6.8% during the forecast period 2023-2033.
06 June 2023
Visiongain Publishes Agricultural Robots Market Report 2023-2033
The global Agricultural Robots market was valued at US$12.8 billion in 2022 and is projected to grow at a CAGR of 25.3% during the forecast period 2023-2033.
31 May 2023
Visiongain Publishes Vegetable Oil Market Report 2023-2033
The global Vegetable Oil market was valued at US$323.18 billion in 2022 and is projected to grow at a CAGR of 6.2% during the forecast period 2023-2033.
25 May 2023
